OUTSIDE FLAP OUTSIDE BACK OUTSIDE FRONT Clinical & Laboratory Evidence safeguarding patient environments™ For more information, contact your Clorox Healthcare sales representative. Call 800-234-7700, email: [email protected] or visit us: www.cloroxhealthcare.com safeguarding patient environments™ © 2016 Clorox Professional Products Company, 1221 Broadway, Oakland, CA 94612. 9 ARTWORK RETRIEVAL APPROVAL P&T REVIEW FILE NAME PG # PROJECT TITLE 48473 UV Clinical Lab Research Collateral ARTWORK STAGE PRINT INFO Litho / (4/0) PRE MECH RELEASE DATE / VENDOR 00/00/00 / i4Color ROUND DATE BRAND PPD HC SUBSTRATE 100# Gloss Cover UPC # PROJECT MGR. / EXT. Michelle Ogata x 7511 DIMENSIONS APPLICATION/ VERSION 27.609375" W x 12.76" H Illustrator CC Dielines do not print. NOTES SPOT COLORS DESIGN REFERENCE ARTWORK & IMAGES USAGE RIGHTS DATE Rights: (File Name or Description) and Source 118203055_GTY_RF_Newborn_ca.psd (GETTY) NI-30486_PPD_UVDevice_Version4_Blue_0815_i3.psd (CCS)

KILLS more than HAI-causing pathogens in 5 minutes at 8 feet.Performance Validated by Third-Party Laboratory Micro-Efficacy Testing Including: • 4-log reduction of C. difficile spores • Greater than 5-log reduction of over 20 pathogens, including MRSA, VRE and CRE Testing Distance and Time: 8 feet, 5 minutes t Via bovine viral diarrhea virus surrogate $ Via feline cal

The Optimum-UV® System reduced C. difficile infection (CDI) rates by 25% and averted $134,568-$191,604 annual direct medical costs in Hematology/Oncology units. Principal Investigator: David Pegues, MD, Professor of Medicine, Hospital of the University of Pennsylvania Purpose: To examine the impact of Optimum-UV® System deployment combined with manual surface disinfection with bleach on C. difficile infection rates in Hematology/Oncology units over a 12-month evaluation period. Methods: The Optimum-UV® System was deployed for a 12-month intervention period, in combination with standard manual...

Johns Hopkins Hospital The Optimum-UV® System achieved a >5 log reduction against carbapenem-resistant Enterobacteriaceae (CRE; K. pneumoniae, E. coli, and E. cloacae) in patient rooms. Principal Investigator: Lisa Maragakis, MD, MPH, Senior Director of Infection Prevention and Associate Professor of Medicine, The Johns Hopkins Health System Purpose: To examine Optimum-UV® System efficacy against carbapenem-resistant Enterobacteriaceae (CRE; K. pneumoniae, E. coli and E. cloacae) plated on Formica®. This study is part of a cluster, randomized, two-period crossover trial focused on evaluating...

Cleveland Clinic Optimum-UV® System effectively reduced the presence of multidrugresistant organisms (MDROs), including C. difficile and methicillin-resistant Staphylococcus aureus (MRSA) in patient rooms. Principal Investigators: Abhishek Deshpande, MD, PhD, Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University Curtis Donskey, MD, Professor of Medicine, Case Western Reserve University and Staff Physician, Infectious Diseases Section, Louis Stokes Cleveland VA Medical Center Purpose: To examine Optimum-UV® System effectiveness against...

Louis Stokes Cleveland VA Medical Center The Optimum-UV® System effectively kills C. difficile and methicillinresistant Staphylococcus aureus (MRSA); standardized UV-C device efficacy testing is needed so that different devices can be compared. Principal Investigator: Curtis Donskey, MD, Professor of Medicine, Case Western Reserve University and Staff Physician, Infectious Diseases Section, Louis Stokes Cleveland VA Medical Center Purpose: To determine the impact of variation in UV-C efficacy test methods on log reduction results. Methods: Two UV-C devices, including the Optimum-UV® System, were...

Principal Investigator: William Rutala, MS, MPH, PhD, Director of Hospital Epidemiology, UNC School of Medicine Purpose: To examine Optimum-UV® System efficacy against methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Klebsiella pneumoniae (CRKP) plated on Formica®, using two different device placement methods. Methods: UV-C was applied to clinical isolates of MRSA and carbapenem-resistant Klebsiella pneumoniae (CRKP) plated on Formica® laminate placed at various locations in a patient room. Two separate experiments were run using two different UV device placement setups...

The Optimum-UV® System is effective against methicillin-resistant Staphylococcus aureus (MRSA) and C. difficile plated on Formica® laminate in patient rooms. Principal Investigator: William Rutala, MS, MPH, PhD, Director of Hospital Epidemiology, UNC School of Medicine Purpose: To examine Optimum-UV® System efficacy against methicillin-resistant Staphylococcus aureus (MRSA) and C. difficile spores plated on Formica®. Methods: UV-C was applied to MRSA and C. difficile spores plated on Formica® laminate placed at various locations in two patient rooms. The UV device was run for either a single 5-minute...

The Optimum-UV® System effectively inactivates C. difficile spores, MS-2 virus and MRSA on long-term care fomites when used in conjunction with Clorox Healthcare® Hydrogen Peroxide. Principal Investigator: Charles Gerba, PhD, Professor, Microbiology & Environmental Sciences, University of Arizona Purpose: To examine the effectiveness of the Optimum-UV® System combined with Clorox Healthcare® Hydrogen Peroxide against C. difficile spores, MS-2 virus and MRSA. Methods: C. difficile spores, MS-2 virus and MRSA were plated on stainless steel, and MRSA was additionally plated on Formica® and 100%...

OASIS Hospital Principal Investigator: Maurice Croteau, Director of Healthcare Services, Western Paper Distributors Purpose: To demonstrate the effectiveness of a simple test method to evaluate microbial load reduction in hospital rooms following treatment with UV-C. Methods: High-touch surfaces were sampled before and after UV-C treatment using RODAC™ contact plates. More than 30 surface types were tested in operating rooms, burn units, intensive care units and a special procedures unit in two hospitals. Results: A simple, easy-to-use microbial test showed that the Optimum-UV® System significantly...